Melissa M. Chen, MD

Melissa M. Chen, MD


Aug. 14, 2024—Neuro-oncologists’ management plans changed in a substantial fraction of adult patients with high-grade glioma (HGG) who underwent advanced neuroimaging to further evaluate conventional MRI findings equivocal for tumor progression versus treatment effect, according to the American Journal of Roentgenology (AJR), published by the AmericanRoentgen Ray Society.

“The impact of advanced neuroimaging techniques on management decisions supports their incorporation into imaging protocols for treatment monitoring in adult patients with HGG,” wrote corresponding author Melissa M. Chen, MD, from the neuroradiology department at the University of Texas MD Anderson Cancer Center in Houston.

Performed at the brain and spine institute of a comprehensive cancer center from March 1, 2017, to October 31, 2020, Chen et al.’s prospective AJR study included adult patients treated by chemoradiation for WHO grade 4 diffuse glioma who underwent MRI-based advanced neuroimaging (comprising multiple perfusion imaging sequences and spectroscopy) to further evaluate findings on conventional MRI equivocal for tumor progression versus treatment effect. The ordering neuro-oncologists completed surveys before and after each advanced neuroimaging session. The percent of care episodes with a change between the intended and actual management plan on the surveys conducted before and after advanced neuroimaging, respectively, was computed and compared with a previously published percentage using independent-sampled proportions.

Ultimately, neuro-oncologists’ intended and actual management plans before and after advanced neuroimaging, respectively, differed in 44 percent of care episodes for patients with HGG and equivocal posttreatment findings on conventional MRI. Neuro-oncologists found advanced neuroimaging to be helpful in 93 percent of episodes.

The American Roentgen Ray Society (ARRS) remains dedicated to the advancement of medicine through the profession of medical imaging and its allied sciences. ARRS maintains its mission of improving health through a community committed to advancing knowledge and skills. 


Related Content

News | Neuro Imaging

June 12, 2024 — Brainet, a developer of cutting-edge diagnostic tools for assessing brain health, and SimonMed Imaging ...

Time June 12, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 9, 2024 — Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It ...

Time February 09, 2024
arrow
News | Neuro Imaging

April 5, 2022 — Imeka, a leading neuroimaging company combining diffusion imaging and AI to map white matter integrity ...

Time April 05, 2022
arrow
News | Neuro Imaging

January 19, 2022 — Recent advances in brain imaging techniques facilitate accurate, high-resolution observations of the ...

Time January 19, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

December 23, 2021 — Advancements in medical science have allowed the treatment of psychiatric disorders like major ...

Time December 23, 2021
arrow
Videos | Coronavirus (COVID-19)

Scott Faro, M.D., professor of radiology and neurology and director, division of neuroradiology, head and neck, at ...

Time December 03, 2021
arrow
News | Neuro Imaging

July 2, 2021 — Researchers at the University of Chicago and the U.S. Department of Energy's (DOE) Argonne National ...

Time July 02, 2021
arrow
Videos | Artificial Intelligence

Pooja Rao, Ph.D., co-founder of Qure.AI and head of research and development for the company, explains how the company's ...

Time July 31, 2020
arrow
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

Four recent radiology studies, from New York, Italy, Iran and China, show how COVID-19 (SARS-CoV-2) impacts the brain of ...

Time July 06, 2020
arrow
News | Nuclear Imaging

December 26, 2019 — The Feinstein Institutes for Medical Research has received U.S. Food and Drug Administration (FDA) ...

Time December 26, 2019
arrow
Subscribe Now